Wholesale of pharmaceutical and medical goods
GRANMO AS
Revenue 2025
NOK 373,000
Operating profit
NOK −290,000
Equity
NOK 6.7m
Incorporated
2005
Share capital
NOK 3.0m
Key figures · 2025
Current ratio
30.24
Equity ratio
99.4%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -77.7% | |
| Net margin (%%) | -74.8% | |
| Return on assets (%%) | -4.3% | |
| Likviditet | ||
| Current ratio | 30.24 | |
| Working capital | 1.2m | |
| Soliditet | ||
| Equity ratio (%%) | 99.4% | |
| Debt-to-equity ratio | 0.01 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.